Showing results (1191-1200 of 1,205) with videos related to
Sort By:
Pageof 121
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2021
Empirical audit and review and an assessment of evidentiary value in research on the psychological consequences of scarcityMichael O'Donnell, Amelia S Dev, Stephen Antonoplis, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2021
Human Cord Blood B Cells Differ from the Adult Counterpart by Conserved Ig Repertoires and Accelerated Response DynamicsBettina Budeus, Artur Kibler, Martina Brauser, et al.Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.Journal of Medicinal Chemistry|May 28, 2004
Discovery and evaluation of potent P1 aryl heterocycle-based thrombin inhibitorsMary Beth Young, James C Barrow, Kristen L Glass, et al.Gut|August 4, 2019
How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery)Ans Pauwels, Veerle Boecxstaens, Christopher N Andrews, et al.Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseasesVinay M Girijavallabhan, Lei Chen, Chaoyang Dai, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2009
The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitorsKristin E Rosner, Zhuyan Guo, Peter Orth, et al.Bioorganic & Medicinal Chemistry Letters|July 20, 2010
Structure and activity relationships of tartrate-based TACE inhibitorsDansu Li, Janeta Popovici-Muller, David B Belanger, et al.Journal of the National Cancer Institute|December 1, 1987
Radiation dose and leukemia risk in patients treated for cancer of the cervixJ D Boice, M Blettner, R A Kleinerman, et al.Pageof 121